Line 277: | Line 277: | ||
<br> | <br> | ||
<br> | <br> | ||
− | <h2 style="text-align: right; color: #44414d">The selection of an integration target site, | + | <h2 style="text-align: right; color: #44414d">The selection of an <span style="color: #7ccfb8">integration |
− | methodology pertaining to gene | + | target site</span>, |
− | + | methodology pertaining to <span style="color: #7ccfb8">gene | |
+ | delivery</span>, and <span style="color: #7ccfb8">maintenance</span> of gene expression | ||
+ | currently limit the potential for gene | ||
+ | therapy | ||
to become common practice.</h2> | to become common practice.</h2> | ||
</div> | </div> |
Revision as of 02:03, 18 October 2018
SNIP EQUIP FLIP
Advancements in genetic modification have opened avenues towards numerous tracks of scientific development.
In particular, the demand for permanent health solutions has sparked massive interest in gene therapy.
Despite the potential for establishing an ideal medicine, there are still numerous challenges.
The selection of an integration target site, methodology pertaining to gene delivery, and maintenance of gene expression currently limit the potential for gene therapy to become common practice.
Use arrow keys
or scroll
or scroll